1. Understand the common and uncommon clinical presentations of myasthenia gravis.
  2. Understand the mechanism of action and data supporting the emerging immunotherapies for myasthenia gravis, including complement inhibitors and FcRN inhibitors.
  3. Understand the importance of reaching the underserved population of patients struggling with myasthenia gravis.
Session date: 
12/06/2023 - 8:00am to 9:00am CST
Location: 
D1.602
United States
See map: Google Maps
Add to calendar: 
  • 1.00 AMA
  • 1.00 Attendance
Please login or create an account to take this course.